510 related articles for article (PubMed ID: 26395218)
1. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays.
Bozkurt-Guzel C; Inci G; Oyardi O; Savage PB
Curr Microbiol; 2020 Aug; 77(8):1419-1428. PubMed ID: 32189050
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
Somily AM; Absar MM; Arshad MZ; Al Aska AI; Shakoor ZA; Fatani AJ; Siddiqui YM; Murray TS
Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
[TBL] [Abstract][Full Text] [Related]
7. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
Vidaillac C; Benichou L; Duval RE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Etest method for detecting colistin susceptibility of multidrug-resistant Gram-negative isolates in Vietnam.
Nhung PH; Miyoshi-Akiyama T; Phuong DM; Shimada K; Anh NQ; Binh NG; Thanh do V; Ohmagari N; Kirikae T
J Infect Chemother; 2015 Aug; 21(8):617-9. PubMed ID: 25960156
[TBL] [Abstract][Full Text] [Related]
11. Assessment of early combination effects of colistin and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii in dynamic time-kill experiments.
Tängdén T; Karvanen M; Friberg LE; Odenholt I; Cars O
Infect Dis (Lond); 2017 Jul; 49(7):521-527. PubMed ID: 28264618
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
Thamlikitkul V; Tiengrim S
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
[TBL] [Abstract][Full Text] [Related]
13. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
Cai Y; Wang R; Liang BB; An MM
J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
[No Abstract] [Full Text] [Related]
14. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
[TBL] [Abstract][Full Text] [Related]
15. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
Ece G; Samlioglu P; Atalay S; Kose S
Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
[TBL] [Abstract][Full Text] [Related]
17. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
Pankuch GA; Seifert H; Appelbaum PC
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the potential for resistance development to ceragenin CSA-13.
Pollard JE; Snarr J; Chaudhary V; Jennings JD; Shaw H; Christiansen B; Wright J; Jia W; Bishop RE; Savage PB
J Antimicrob Chemother; 2012 Nov; 67(11):2665-72. PubMed ID: 22899801
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
20. Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan.
Hameed F; Khan MA; Muhammad H; Sarwar T; Bilal H; Rehman TU
Rev Soc Bras Med Trop; 2019 Sep; 52():e20190237. PubMed ID: 31508785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
